MORRISVILLE, NC, AUG 1, 2017 – Worldwide Clinical Trials (www.worldwide.com) announced that PharmaVOICE has named its Chief Medical and Scientific Officer, Michael F. Murphy, M.D., Ph.D., as one of the top 100 most influential and inspirational leaders in the life-sciences industry. Selected among hundreds of nominees, Dr. Murphy has been recognized for his dedication and passion in driving innovations, as well as the instrumental role he has played in building Worldwide into one of the industry’s leading CROs.
With a career spanning more than 30 years, Dr. Murphy does what few people can, inspiring a new standard for clinical development services, emphasizing strategic relationships across multiple stakeholders and the integration of medical and scientific ingenuity with operational excellence.
“We are delighted that Dr. Murphy has been recognized in this year’s PharmaVOICE 100, as his dedication and commitment have been key to driving the company forward,” commented Peter Benton, president and COO, Worldwide Clinical Trials. “He has challenged the norm and urged us to look at different ways of improving trial design and patient outcomes across studies. This award is a testament to Dr. Murphy’s contributions to the industry, as well as to the skills and expertise of all Worldwide team members to deliver uncommon value to sponsors, investigators and patients.”
Launched in 2005, the PharmaVOICE 100 identifies and celebrates the most influential and inspirational men and women in the life-sciences industry, honoring individuals who inspire their peers, colleagues and companies through innovation to address the industry’s myriad of challenges. Each year, the July/August issue of PharmaVOICE magazine draws attention to these individuals, highlighting their achievements and contributions to the industry.
“We are honored to include Dr. Murphy on this year’s list of the PharmaVOICE 100 most inspiring individuals in the life-sciences industry,” said Taren Grom, editor of PharmaVOICE. “Dr. Murphy is known as a true visionary throughout the industry for his dedication and passion to drive innovation in clinical trials. His considerable efforts have positively impacted many through his unwavering commitment to integrating scientific acumen with operational excellence across studies for all parties involved.”
The PharmaVOICE 100 is the latest in a series of awards that honor and recognize Worldwide’s uncommon, proven approach to CRO excellence. Since the start of 2017, Worldwide Clinical Trials have been honoured in some of the industry’s leading award programs, including Life Science Leader’s CRO Leadership Awards and the CARE Awards, where Dr. Murphy was presented with the ‘Lifetime Achievement Award’ and Worldwide Clinical Trials was selected as a finalist in the ‘Clinical Partnership of the Year’ category. Most recently, Worldwide Clinical Trial’s CEO, Dr. Neal Cutler, was awarded the European CEO Award for ‘Best CEO in the CRO Industry’, in recognition for his leadership in pivotal clinical trials and success as a clinical researcher.
For further information about Worldwide Clinical Trials, please visit Worldwide.com.
Connect with Worldwide Clinical Trials:
- Tweet: Dr. Michael Murphy of @Worldwidetrials recognized at this year’s PharmaVOICE 100
- Follow us on Twitter: @worldwidetrials
- Find us on LinkedIn: https://www.linkedin.com/company/worldwide-clinical-trials-inc-
About Worldwide Clinical Trials
Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way. From Early Phase and Bioanalytical Sciences through Late Phase and post approval, we provide world-class, full-service drug development services. With infrastructure and talent spanning 60 countries, we execute predictable, successful studies with operational excellence. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO. For more information, visit Worldwide.com.
Worldwide Clinical Trials